Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Companies / BioAffinity Technologies
Company

BioAffinity Technologies

Tracked across 1 events · 6 articles · First seen Aug 13, 2026 · Last active Aug 14, 2026

Sentiment
10
Attention
1
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
1 10
Business
bioAffinity Technologies $4M Private Placement
BioAffinity Technologies, Inc., a biotechnology company focused on noninvasive diagnostics and early cancer detection, announced the closing of its previously announced private placement priced at-the-market under Nasdaq rules. The offering involved the sale of pre-funded…
Impact: BioAffinity Technologies is the issuer of the private placement, raising approximately $4.0 million in gross proceeds. The offering provides additional capital but may result in future dilution due to the warrants.
Aug 13, 2026 · 6 articles
Key Actions (2)
100 BioAffinity Technologies closed private placementbioAffinity Technologies...
80 WallachBeth Capital acted as placement agent BioAffinity TechnologiesbioAffinity Technologies...
ERGEN INTELLIGENCE
Track BioAffinity Technologies live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.